AcaRevival Initiative
Experienced academic misconduct or bullying? We're building a real weapon against it.
OL
Orly Leiva
Hematology
Harvard University
No ratings yetBe the first to rate
Loading...
About Orly Leiva at Harvard University (Harvard)
Based at Harvard University, Orly Leiva focuses their scholarly efforts on Myeloproliferative Neoplasms, Eosinophilic Disorders, Venous Thromboembolism, Cardiovascular Outcomes, Pulmonary Hypertension, Immune Checkpoint Inhibitors, β-blocker Therapy, COVID-19 Complications, bridging the gap between theory and practice in Myeloproliferative Neoplasms.
A representative example of their recent contribution is the study titled "Outcomes of Patients With Myeloproliferative Neoplasms Admitted With Myocardial Infarction", which offers critical insights into the dynamics of Myeloproliferative Neoplasms and Eosinophilic Disorders. Additional work such as "Off-Target Effects of Cancer Therapy on Development of Therapy-Induced Arrhythmia: A Review" further demonstrates their commitment to advancing knowledge in this domain.
Research Areas
Myeloproliferative NeoplasmsEosinophilic DisordersVenous ThromboembolismCardiovascular OutcomesPulmonary HypertensionImmune Checkpoint Inhibitorsβ-blocker TherapyCOVID-19 Complications
Top Publications
- 1
- 2
Reviews (0)
No reviews yet for this supervisor.
Be the first to share your experience!
Is your PI driving you crazy?
Featured Article
The Sunday Night Dread: Surviving a Micromanaging PhD Supervisor
Real advice from PhD students on recognizing and navigating difficult supervisor relationships
Your experience matters. After reading the guide, share your review to help other PhD students.
Frequently Asked Questions
Not sure how to interpret mixed signals? A structured decision guide can help you think through high-risk supervision choices more clearly. Download the free guide.